Session two  4 th  March 2011
Substance abuse treatment
Aims to identify substance abuse problems and motivate individuals to address their use 5-30 min sessions/intervention Strong evidence supporting use with alcohol and tobacco and growing evidence for other substances Studies have shown a reduction in alcohol intake for participants who underwent 15 min sessions and received educational material
Cost effective Useful for other primary care workers who have patients who are unwilling to access specialised substance abuse counselling Can involve a variety of approaches Successful with at risk users or less severe abuse behaviours
A drug strategy based on a harm minimisation approach has the following primary objectives:  to minimise the harm and the social problems to the individual and the community resulting from the use of drugs  to reduce the prevalence of hazardous levels and patterns of drug use in the community; and  to prevent the initiation into harmful or hazardous drug use, especially by young people. (NSW Health Department 1999:A5)
Examples; Needle and Syringe Programs (NSPs) Substitute Medication Prescribing (e.g. opioid substitution therapy) Overdose Prevention (e.g. Naloxone, first aid training) Drug Consumption Rooms Outreach and Peer Education
Optional reading on human rights and harm reduction; International Harm Reduction Association. (n.d.)  Harm Reduction Policy and Practice Worldwide . Retrieved from h ttp://www.ihra.net/files/2010/11/01/IHRA_Briefing_1.pdf
Research difficult due to issues defining terms and outcomes however numerous studies have found benefit for those who complete the full program (high drop out rate). More than one treatment episode may be required (one third of drop outs seek re-admittance) In one study 83% of participants said they would recommend a TC to others
Page 219-255 of the following reading provides excellent information in relation to research evidence for TCs Australasian Therapeutic Communities Association. (2002). Towards Better Outcomes for Therapeutic Communities. Retrieved from  http://www.atca.com.au/04_resources/Towards%20Better%20Practice%20in%20Therapeutic%20Communities.pdf
Relapse prevention therapy consists of a number of key ingredients; reducing   exposure to substances fostering motivation for abstinence self-monitoring (situations, settings,   and states) recognizing and coping with cravings and negative   affect identifying thought processes with relapse potential,   and if necessary, a crisis plan.
Aspects of relapse prevention have been incorporated into most psychosocial treatments for substance use Access the following link for more information on relapse prevention http://psychservices.psychiatryonline.org/cgi/content/full/56/10/1270
1. No single treatment is appropriate for all 2. Treatment needs to be readily available 3. Effective treatment attends to the multiple needs of the individual 4. Treatment plans must be assessed and modified continually to meet changing needs 5. Remaining in treatment for an adequate period of time is critical for treatment effectiveness
6.  Counseling and other behavioral therapies are critical components of effective treatment 7.  Medications are an important element of treatment for many patients 8.  Co-existing disorders should be treated in an integrated way
9.  Medical detox is only the first stage of treatment 10. Treatment does not need to be voluntary to be effective 11. Possible drug use during treatment must be monitored continuously
12. Treatment programs should assess for HIV/AIDS, Hepatitis B & C, Tuberculosis and other infectious diseases and help clients modify at-risk behaviors 13. Recovery can be a long-term process and frequently requires multiple episodes of treatment NIDA (1999)  Principles of Drug Addiction Treatment
Mental health
Choose one of the following mental health interventions and prepare a 5 minute presentation on what the best practice model is and the evidence which supports it. This info is to be presented in the next class. Illness management and recovery Illness self management Assertive Community Treatment (ACT) for person’s with severe mental illness Psychosocial rehabilitation Integrated service delivery for co-morbidity (AOD & MH issues) Supported employment

More Related Content

PPTX
Pharmacoeconomics & drug compliance
PPTX
Supporting medicines adherence developing the pharmacist contribution
PDF
Medication Adherence in the Real World
PPTX
The NHS’ vision for medicines optimisation - the role for pharma in driving ...
PPTX
Patient data analysis
PDF
Drug utilization evaluation
PDF
A prospective-medical-system-of-the-futurea-complete-health-care-system
PPTX
Case control surveillance
Pharmacoeconomics & drug compliance
Supporting medicines adherence developing the pharmacist contribution
Medication Adherence in the Real World
The NHS’ vision for medicines optimisation - the role for pharma in driving ...
Patient data analysis
Drug utilization evaluation
A prospective-medical-system-of-the-futurea-complete-health-care-system
Case control surveillance

What's hot (20)

PPT
Measurement of outcomes in pharacoepidemiology
DOCX
Medication Errors Complete
PPT
Policy recommendations for improved medication adherence in Europe: the ABC P...
PPTX
Current drugs trends nuring education
PPTX
(DUE) Drug use evaluation
PPTX
Definition and scope of Pharmacoepidemiology
PPTX
Drug Utilization review
PPTX
Pharmacoepidemiology
PPTX
Measurement of medication adherence
PPTX
EBP Presentation
PPTX
Epidemiology trends and healthcare implication
PDF
Homeopathy – what are the active ingredients? An exploratory study using the ...
PPTX
Pharmaceutical care
PDF
Medipex innovation awards 2015 press release
PPTX
Journal club -pharmacist intervention in cost saving.
PPTX
Therapeutic drug monitoring
PPT
Measurement of outcomes in epidemiology
DOCX
Epidemiological trends and health care implication
PDF
What do clinicians want? Interest in integrative health services at a North C...
PPTX
Prof. Judith H. Hibbard: The King's Fund Annual Conference
Measurement of outcomes in pharacoepidemiology
Medication Errors Complete
Policy recommendations for improved medication adherence in Europe: the ABC P...
Current drugs trends nuring education
(DUE) Drug use evaluation
Definition and scope of Pharmacoepidemiology
Drug Utilization review
Pharmacoepidemiology
Measurement of medication adherence
EBP Presentation
Epidemiology trends and healthcare implication
Homeopathy – what are the active ingredients? An exploratory study using the ...
Pharmaceutical care
Medipex innovation awards 2015 press release
Journal club -pharmacist intervention in cost saving.
Therapeutic drug monitoring
Measurement of outcomes in epidemiology
Epidemiological trends and health care implication
What do clinicians want? Interest in integrative health services at a North C...
Prof. Judith H. Hibbard: The King's Fund Annual Conference
Ad

Viewers also liked (9)

PPT
Christian Personal Checks
PPTX
Chcaod511 b session five 310311
PPTX
Mental health cluster a session two 280411
PPT
Chcaod511 b session seven 280411
PPTX
Chcaod511 b session six 070411
PPTX
Mental health cluster a session two 280411
PPT
Chcaod511 b session four
PPTX
Mental health cluster a session two 280411
PDF
Управление выручкой розничного предприятия
Christian Personal Checks
Chcaod511 b session five 310311
Mental health cluster a session two 280411
Chcaod511 b session seven 280411
Chcaod511 b session six 070411
Mental health cluster a session two 280411
Chcaod511 b session four
Mental health cluster a session two 280411
Управление выручкой розничного предприятия
Ad

Similar to Chcpol501 a session two 040311 (20)

DOCX
Research MethodsLaShanda McMahonUniversity o.docx
DOCX
The Brief Wondrous Life of Oscar Wao.docx
PPTX
Unit 3 drug utilization research (6hrs) march 12 2021
PDF
SMOKING CESSATION _ CODP 8
 
PPTX
Drug Addiction Final pptx
PDF
Assessment of Community Pharmacists’ Involvement in the Rehabilitation of Dru...
PDF
Clinical review supporting smoking cessationqqqqqqq11111
PDF
Www.drugabuse.gov/sites/default/files/files/pami factsheet
PDF
CDC 2018-Evidence-Based-Strategies For Preventing Opioid Overdose
PPTX
Managed Access Programs: Timely, Appropriate, Sustainable Access for Rare Dis...
PPT
Harm reduction atma jaya
DOCX
Key Stakeholders in Public Health Issue.docx
PPTX
UNIT-I Pharmacoepidemiology and Pharmacoeconomics
PPTX
Mr. G. Charanjit Sharma_Harm reduction for PWID and counseling needs_14-08-20...
PPT
Point of Care
DOCX
Dana harm reduction 2
DOCX
Sheet1ParticipantNo MedsMeds11113214163101441217581161514712158131.docx
PDF
Effect of Behavioral Intervention on Reducing Symptom Severity during First C...
PDF
Solution Manual for Introduction to Health Care 4th Edition Mitchell Haroun 1...
PDF
The Role of Medicinal Plants in Enhancing Patient Adherence to Treatment (ww...
Research MethodsLaShanda McMahonUniversity o.docx
The Brief Wondrous Life of Oscar Wao.docx
Unit 3 drug utilization research (6hrs) march 12 2021
SMOKING CESSATION _ CODP 8
 
Drug Addiction Final pptx
Assessment of Community Pharmacists’ Involvement in the Rehabilitation of Dru...
Clinical review supporting smoking cessationqqqqqqq11111
Www.drugabuse.gov/sites/default/files/files/pami factsheet
CDC 2018-Evidence-Based-Strategies For Preventing Opioid Overdose
Managed Access Programs: Timely, Appropriate, Sustainable Access for Rare Dis...
Harm reduction atma jaya
Key Stakeholders in Public Health Issue.docx
UNIT-I Pharmacoepidemiology and Pharmacoeconomics
Mr. G. Charanjit Sharma_Harm reduction for PWID and counseling needs_14-08-20...
Point of Care
Dana harm reduction 2
Sheet1ParticipantNo MedsMeds11113214163101441217581161514712158131.docx
Effect of Behavioral Intervention on Reducing Symptom Severity during First C...
Solution Manual for Introduction to Health Care 4th Edition Mitchell Haroun 1...
The Role of Medicinal Plants in Enhancing Patient Adherence to Treatment (ww...

Chcpol501 a session two 040311

  • 1. Session two 4 th March 2011
  • 3. Aims to identify substance abuse problems and motivate individuals to address their use 5-30 min sessions/intervention Strong evidence supporting use with alcohol and tobacco and growing evidence for other substances Studies have shown a reduction in alcohol intake for participants who underwent 15 min sessions and received educational material
  • 4. Cost effective Useful for other primary care workers who have patients who are unwilling to access specialised substance abuse counselling Can involve a variety of approaches Successful with at risk users or less severe abuse behaviours
  • 5. A drug strategy based on a harm minimisation approach has the following primary objectives: to minimise the harm and the social problems to the individual and the community resulting from the use of drugs to reduce the prevalence of hazardous levels and patterns of drug use in the community; and to prevent the initiation into harmful or hazardous drug use, especially by young people. (NSW Health Department 1999:A5)
  • 6. Examples; Needle and Syringe Programs (NSPs) Substitute Medication Prescribing (e.g. opioid substitution therapy) Overdose Prevention (e.g. Naloxone, first aid training) Drug Consumption Rooms Outreach and Peer Education
  • 7. Optional reading on human rights and harm reduction; International Harm Reduction Association. (n.d.) Harm Reduction Policy and Practice Worldwide . Retrieved from h ttp://www.ihra.net/files/2010/11/01/IHRA_Briefing_1.pdf
  • 8. Research difficult due to issues defining terms and outcomes however numerous studies have found benefit for those who complete the full program (high drop out rate). More than one treatment episode may be required (one third of drop outs seek re-admittance) In one study 83% of participants said they would recommend a TC to others
  • 9. Page 219-255 of the following reading provides excellent information in relation to research evidence for TCs Australasian Therapeutic Communities Association. (2002). Towards Better Outcomes for Therapeutic Communities. Retrieved from http://www.atca.com.au/04_resources/Towards%20Better%20Practice%20in%20Therapeutic%20Communities.pdf
  • 10. Relapse prevention therapy consists of a number of key ingredients; reducing exposure to substances fostering motivation for abstinence self-monitoring (situations, settings, and states) recognizing and coping with cravings and negative affect identifying thought processes with relapse potential, and if necessary, a crisis plan.
  • 11. Aspects of relapse prevention have been incorporated into most psychosocial treatments for substance use Access the following link for more information on relapse prevention http://psychservices.psychiatryonline.org/cgi/content/full/56/10/1270
  • 12. 1. No single treatment is appropriate for all 2. Treatment needs to be readily available 3. Effective treatment attends to the multiple needs of the individual 4. Treatment plans must be assessed and modified continually to meet changing needs 5. Remaining in treatment for an adequate period of time is critical for treatment effectiveness
  • 13. 6. Counseling and other behavioral therapies are critical components of effective treatment 7. Medications are an important element of treatment for many patients 8. Co-existing disorders should be treated in an integrated way
  • 14. 9. Medical detox is only the first stage of treatment 10. Treatment does not need to be voluntary to be effective 11. Possible drug use during treatment must be monitored continuously
  • 15. 12. Treatment programs should assess for HIV/AIDS, Hepatitis B & C, Tuberculosis and other infectious diseases and help clients modify at-risk behaviors 13. Recovery can be a long-term process and frequently requires multiple episodes of treatment NIDA (1999) Principles of Drug Addiction Treatment
  • 17. Choose one of the following mental health interventions and prepare a 5 minute presentation on what the best practice model is and the evidence which supports it. This info is to be presented in the next class. Illness management and recovery Illness self management Assertive Community Treatment (ACT) for person’s with severe mental illness Psychosocial rehabilitation Integrated service delivery for co-morbidity (AOD & MH issues) Supported employment